152 related articles for article (PubMed ID: 17712032)
1. The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma.
Sakano S; Hinoda Y; Okayama N; Kawai Y; Korenaga Y; Eguchi S; Nagao K; Ohmi C; Naito K
Ann Oncol; 2007 Nov; 18(11):1817-27. PubMed ID: 17712032
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
3. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
4. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma.
Qin C; Cao Q; Ju X; Wang M; Meng X; Zhu J; Yan F; Li P; Ding Q; Chen J; Gu M; Zhang W; Yin C; Zhang Z
Ann Oncol; 2012 Apr; 23(4):981-9. PubMed ID: 21778301
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R
Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122
[TBL] [Abstract][Full Text] [Related]
6. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
7. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
[TBL] [Abstract][Full Text] [Related]
9. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
10. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
11. DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patients.
Bachmann HS; Rübben H; Schmid KW; Siffert W; Riemann K
Anticancer Res; 2009 Dec; 29(12):5131-5. PubMed ID: 20044627
[TBL] [Abstract][Full Text] [Related]
12. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
[TBL] [Abstract][Full Text] [Related]
13. hOGG1 Ser326Cys polymorphism and renal cell carcinoma risk in a Chinese population.
Zhao H; Qin C; Yan F; Wu B; Cao Q; Wang M; Zhang Z; Yin C
DNA Cell Biol; 2011 May; 30(5):317-21. PubMed ID: 21166493
[TBL] [Abstract][Full Text] [Related]
14. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
15. A functional polymorphism C-1310G in the promoter region of Ku70/XRCC6 is associated with risk of renal cell carcinoma.
Wang W; Pan X; Huo X; Yan F; Wang M; Wang D; Gao Y; Cao Q; Luo D; Qin C; Yin C; Zhang Z
Mol Carcinog; 2012 Oct; 51 Suppl 1():E183-90. PubMed ID: 22593040
[TBL] [Abstract][Full Text] [Related]
16. The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Lin YC; Chen WJ; Huang CY; Shiue HS; Pu YS; Chen CH; Su CT
Toxicol Appl Pharmacol; 2017 Oct; 332():1-7. PubMed ID: 28733204
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
[TBL] [Abstract][Full Text] [Related]
18. DNA repair gene polymorphisms may be associated with prognosis of upper urinary tract transitional cell carcinoma.
Sasaki M; Sakano S; Okayama N; Akao J; Hara T; Kawai Y; Ohmi C; Hinoda Y; Naito K
Neoplasia; 2008 Mar; 10(3):255-65. PubMed ID: 18320070
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma.
Chung CJ; Bao BY; Lin YC; Huang YL; Shiue HS; Ao PL; Pu YS; Huang CY; Hsueh YM
Sci Rep; 2020 Apr; 10(1):6640. PubMed ID: 32313131
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]